Effect of Reiki on Neuropathic Pain Severity and Sleep Quality in Patients With Diabetic Neuropathy
TC Erciyes University
60 participants
Nov 1, 2024
INTERVENTIONAL
Conditions
Summary
The study is planned to be conducted in a mixed research design with quantitative and qualitative types. The quantitative phase of the study was planned as a single-blind, randomized controlled study with Reiki group, Sham Reiki group and control group designs in order to examine the effect of second-level (remote application) Reiki applied to patients with diabetic neuropathy for 20 minutes a day for four days on pain intensity, neuropathic pain intensity (DN4 Questionnaire) total scores and sleep quality. The qualitative study will be conducted with 4 people from the Reiki and Sham Reiki groups, a total of 8 patients, one week after the application, using the individual in-depth interview method and a semi-structured questionnaire.
Eligibility
Inclusion Criteria9
- Over 18 years of age
- No communication problems
- Communicating in Turkish
- No diagnosis of mental illness
- Willingness to participate in the study
- Being competent enough to answer forms and surveys
- VAS pain intensity 3 and above
- Question Neuropathic Pain score 4 and above
- Not having received Reiki treatment
Exclusion Criteria6
- Receiving a different illness and treatment during the therapy process
- Leaving Reiki practice
- Psychiatric illness
- Becoming a Reiki practitioner or instructor
- Cerebrovascular disease
- Receiving Reiki practice
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Remote Reiki application will be performed once a day for 20 minutes for four days by a researcher who has received second level training. No changes will be made to the standard treatment plan of the patients during the application.
In the placebo group, the Sham Reiki group will receive remote Reiki application in accordance with the application protocol by a nurse who is not a Reiki practitioner trained by the researcher and has not received any previous training.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06668623